US Broker Ratings

TotalEnergies SE (TTE) Stock Analysis: Evaluating Growth Potential Amid Market Trends

TotalEnergies SE (TTE), a French energy giant with a market cap of $166.48 billion, is making waves in the oil and gas integrated industry. As a multi-energy company, TotalEnergies produces..

Gossamer Bio, Inc. (GOSS) Stock Analysis: Unveiling a Potential 301% Upside in Biotech

Gossamer Bio, Inc. (NASDAQ: GOSS), a San Diego-based clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising pipeline aimed at addressing pulmonary arterial hypertension (PAH). With..

AMTD Digital Inc. (HKD): Inside the 1,085.90% Revenue Growth and What It Means for Investors

AMTD Digital Inc. (HKD), a relatively new player in the technology sector, has been capturing attention with its astounding revenue growth of 1,085.90%. Despite this impressive figure, investors might find..

Immutep Limited (IMMP) Stock Analysis: A 240% Potential Upside in Immunotherapy Breakthrough

Immutep Limited (NASDAQ: IMMP), an innovative player in the biotechnology sector, is capturing the attention of investors with its ambitious focus on developing immunotherapies for cancer and autoimmune diseases. The..

Senseonics Holdings (SENS) Stock Analysis: Is a 145% Upside Within Reach?

Investors eyeing the healthcare sector might find Senseonics Holdings, Inc. (NYSE: SENS) an intriguing prospect, particularly with its impressive projected upside of 145.67%. Specializing in continuous glucose monitoring (CGM) systems,..

Erasca, Inc. (ERAS) Stock Analysis: Navigating the Oncology Frontier with Promising Clinical Trials

Erasca, Inc. (NASDAQ: ERAS), a clinical-stage biotechnology company, is making significant strides in the precision oncology sector, focusing on therapies for RAS/MAPK pathway-driven cancers. With a market capitalization of $3.58..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Exploring a Potential 118.62% Upside in the Medical Devices Sector

SANUWAVE Health, Inc. (NASDAQ: SNWV), a promising player in the healthcare sector, particularly in the medical devices industry, is capturing the attention of investors with its innovative approach to regenerative..

Phathom Pharmaceuticals, Inc. (PHAT): Investor Outlook on an 87% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising pipeline in gastrointestinal therapeutics and an impressive potential upside..

Absci Corporation (ABSI) Stock Analysis: Exploring a 209% Upside Potential in Biotech Innovation

Absci Corporation (NASDAQ: ABSI) stands at the cutting edge of biotechnology, leveraging artificial intelligence to innovate in drug creation. Operating in the burgeoning healthcare sector, Absci is carving out a..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Unpacking a 230% Potential Upside in The Medical Devices Sector

Nano-X Imaging Ltd (NASDAQ: NNOX), a company at the intersection of healthcare and technology, has been gaining attention for its innovative approach in the medical devices sector. Headquartered in Petah..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: Exploring a 307.96% Potential Upside in the Biotech Sector

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector due to its promising pipeline of gene and cell therapies and a compelling potential..

Alumis Inc. (ALMS) Investor Outlook: Biotech Innovator with a 45% Upside Potential

Alumis Inc. (NASDAQ: ALMS), a burgeoning force in the biotechnology sector, is drawing significant attention from investors with its promising pipeline of treatments for autoimmune disorders. As a clinical-stage biopharmaceutical..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Bold 67% Upside Potential

Investors with an eye on the biotechnology sector might find Entrada Therapeutics, Inc. (NASDAQ: TRDA) an intriguing prospect, with a potential upside of 67.12% based on current analyst ratings. This..

Zhengye Biotechnology (ZYBT) Stock Analysis: Can This Chinese Vaccine Maker Rebound from a 52-Week Low?

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Zhengye Biotechnology Holding L (ZYBT), a Chinese company focused on the development and sale of..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unpacking a Potential 94.89% Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling opportunity, driven by its substantial potential upside of 94.89%. As a clinical-stage biopharmaceutical..

Quantum-Si Incorporated (QSI) Investor Outlook: Exploring a Potential 158% Upside

Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative approach to protein sequencing technology. As a life sciences company..

Canopy Growth Corporation (CGC): Investor Outlook Reveals 69% Potential Upside

Canopy Growth Corporation (NASDAQ: CGC), headquartered in Smiths Falls, Canada, continues to be a focal point for investors eyeing the burgeoning cannabis industry. As a major player in the healthcare..

Candel Therapeutics (CADL) Stock Analysis: A Biotech with a 236% Upside Potential

Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering entity in the biopharmaceutical landscape, is capturing investor attention with its impressive potential upside of 236.80%. This clinical-stage biotech company, headquartered in Needham,..

Pacific Biosciences of California (PACB) Stock Analysis: Exploring the 31% Potential Upside

Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands out in the healthcare sector’s medical devices industry, particularly for its innovative solutions in the field of genetic sequencing. Headquartered in Menlo..

Exxon Mobil Corporation (XOM) Stock Analysis: Navigating a Challenging Market with Strategic Stability

Exxon Mobil Corporation (NYSE: XOM), a behemoth in the energy sector with a market capitalization of $656.02 billion, continues to be a focal point for investors seeking stability in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds